Drug Safety & Pharmacovigilance
Reporting suspected adverse reactions of medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals and patients are asked to report any suspected adverse reactions via the Swiss Agency for Therapeutic Products (Swissmedic) at:
Adverse reactions may also be reported directly to Gilead. Adverse reactions related to Gilead products may be reported directly to Gilead via the link below.